◄ back to all posts

CRSP: CRISPR Therapeutics AG Stock

Written by | Jul 6, 2018

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5,900.76
Enterprise Value ($M) 4,900.96
Book Value ($M) 910.67
Book Value / Share 12.98
Price / Book 6.42
NCAV ($M) 829.76
NCAV / Share 11.82
Price / NCAV 7.05

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.14
Return on Equity (ROE) 0.17

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 12.96

Balance Sheet (mrq) ($M)
Current Assets 965.62
Assets 1,046.53
Liabilities 135.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 289.59
Operating Income 46.74
Net Income 66.86
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted 1.17
Earnings Per Share Basic 1.23

Cash Flow Statement (mra) ($M)
Cash From Operations 56.68
Cash from Investing 1.32
Cash from Financing 1.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-09-18 13D/A Versant Venture Capital IV, L.P. 3.00 -7.33
2020-09-11 13G Capital International Investors 10.70 0.00
2020-07-10 13D/A Glaxosmithkline Plc 4.80 0.46
2020-02-13 13G/A Vertex Pharmaceuticals Inc / Ma 4.40 -50.00
2020-02-12 13G Nikko Asset Management Americas, Inc. 5.08
2020-02-12 13G Sumitomo Mitsui Trust Holdings, Inc. 5.08
2020-02-04 13D/A Bayer Global Investments B.v. 4.90 -19.87
2019-02-12 13G/A New Enterprise Associates 15, L.p.
2018-02-08 13D/A Celgene Corp /de/ 6.10 -15.30
2018-01-16 13D/A Abingworth LLP 4.00 -12.07

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-07-27 10-Q Quarterly Report – 10-Q
2020-04-28 10-Q Quarterly Report – 10-Q
2020-02-12 10-K Annual Report – 10-K
2019-10-28 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-09-25 87,613 522,200 16.78
2020-09-24 109,077 534,700 20.40
2020-09-23 111,583 581,000 19.21
2020-09-22 102,927 491,100 20.96
2020-09-21 61,987 482,400 12.85

(click for more detail)

(click for list of largest short owners)

Similar Companies
CRDF – Cardiff Oncology, Inc. CRIS – Curis, Inc.
CRNX – Crinetics Pharmaceuticals, Inc. CRTX – Cortexyme Inc
CRVS – Corvus Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

401 K